TRHC Precision Research and Development Institute COVID-19 Resources
Potential Treatment Options for COVID-19 Medication Chart – See chart
NIH Registered Clinical Trials
Simulation of Risk of Adverse Drug Events Associated with the Initiation of Drugs Repurposed for the Treatment of COVID-19 in Frail Elderly Adults With Polypharmacy – Read more
Simulation of Risk of Adverse Drug Events Associated With the Initiation of Drugs Repurposed for the Treatment of COVID-19 in Adults With Polypharmacy Using Data From Large Medicare and Commercially Insured Populations – Read more
COVID-19 Vaccine Patient Support Services
TRHC’s nationwide MedWiseRx™ clinical contact centers provide HIPAA compliant COVID-19 patient support services for pharmacies, state associations, public health entities, state and county boards, and many other organizations. Read more
COVID-19 Resources for PACE
TRHC’s CareKinesis® COVID-19 resource for PACE page includes information on the coronavirus and COVID-19, including test kits, potential treatment options, webinars, and potential COVID-19 treatment options, and clinical studies.
Pharmacist COVID-19 Resources
TRHC’s PrescribeWellness™ coronavirus webpage includes quick links for pharmacies, including an online order form for COVID-19 test kits, as well as timely collated updates generated from venerable sources such as the Centers for Disease Control and Prevention (CDC) and the World Health Organization (WHO).
During the COVID-19 pandemic, staying healthy is top of mind. For individuals at risk for or diagnosed with COVID-19, the addition of new treatments may pose another medical danger: adverse drug events (ADEs). ADEs cause an estimated 150,000 deaths per year in the United States and 1.3 million emergency room visits, resulting in nearly 350,000 people hospitalized for further treatment.
COVID-19 Related Press Releases
Why COVID-19 Could Pose New Medication Risks Next Avenue By Michele Cohen Marill December 1, 2020 It’s common for older adults to take multiple
Results of Tabula Rasa HealthCare’s First Simulated Clinical Study on Proposed COVID-19 Treatments and Therapies is Published
MOORESTOWN, NJ, (August 12, 2020) – Tabula Rasa HealthCare, Inc® (TRHC) (NASDAQ: TRHC), a healthcare technology company advancing the field of medication safety, announces
Moorestown, NJ, June 9, 2020 – Regence and Tabula Rasa HealthCare® (NASDAQ: TRHC) announced today that the companies have partnered on a virtual clinical trial
Moorestown, NJ, May 19, 2020 – Tabula Rasa HealthCare® Corporation (NASDAQ: TRHC), a healthcare technology company advancing the field of medication safety, today published on
TRHC Launches First Large Simulation Study to Assess Adverse Drug Events with proposed COVID-19 Treatments
Moorestown, NJ, April 29, 2020 – Tabula Rasa HealthCare Corporation® (NASDAQ: TRHC), a healthcare technology company advancing the field of medication safety, announced today it
Tabula Rasa HealthCare and Strategic Solutions Network Partner on a Free COVID-19 Medication Safety Webinar
MOORESTOWN, N.J., April 23, 2020 (GLOBE NEWSWIRE) — Tabula Rasa HealthCare Corporation® (NASDAQ: TRHC), a healthcare technology company advancing the field of medication safety, and